cycling

Lance Armstrong saga brings out the vitriol

Yoda-speak: Hate leads to anger, anger leads … to writing about Lance Armstrong.

As with the opinion on Jon Jones v UFC, mainstream punditry seems to have shifted. Or maybe it just depends on what news organization you read. You’re read my take — either nuanced or wishy-washy, depending on how charitable you are. And I already mentioned George Vecsey’s take, in which the great columnist thinks Armstrong likely wasn’t doing anything others weren’t doing as well.

Let’s see what else is out there:

At USA TODAY, my excellent former colleague Christine Brennan bluntly labels Armstrong a cheater.

The Washington Post, on the other hand, aims both barrels of anger at the U.S. Anti-Doping Agency. Tracee Hamilton: “Either a drug test is the standard, or it isn’t.” (To which Marion Jones could respond, “Wait, I didn’t have to go to jail?”)  Sally Jenkins, who duly gives the disclaimer that she has written with Armstrong, says curiously uses alleged World Anti-Doping Agency misdeeds and ties them to what she sees an overzealous U.S. Anti-Doping Agency, which is a bit like throwing Sepp Blatter’s problems at Sunil Gulati’s feet.

Jenkins also implores Congress to step in and do something about “the WADA-USADA system,” calling it “simply incompatible with the U.S. legal system.”

So … I guess we won’t be sending any more athletes to the Olympics?

That said — Jenkins raises and repeats valid concerns about WADA and international arbitration. But thinking Congress can sort it out sure feels like betting on the wrong horse.

(Update: The Post is far from unanimous — Mike Wise calls Armstrong’s move a vindication of his longtime critics. One point worth mentioning: Armstrong’s critics don’t gain anything financially. Far from it. They stand to lose a lot. It’s not like the old WADA days where Dick Pound used his position to keep his name out there and occasionally tweak Americans.)

How do Armstrong’s sponsors feel? Former USA TODAY colleague Mike McCarthy finds Michelob Ultra sticking with him, and Oakley basically says “Prove it.”

Slate offers two takes — Josh Levin says Armstrong has managed to keep a core of true believers (looking around the Web and my own Facebook feed, I’d argue it’s more than a small core) and his “righteous indignation.” Jeremy Stahl, who has covered cycling, echoes the points Vecsey and I have made — if you strip Lance, who of the other suspected or convicted dopers will take his titles?

The Economist’s Game Theory blog, a good quirky read for those of us who like quirky sports coverage, views the Armstrong saga as a tragedy.

Let’s leave it to Mike Lopresti, a pro’s pro among columnists, to add some gray to the black-and-white case:

What Lance Armstrong shows us is that human nature will never be as straightforward as a box score or a talk show. We are quick to build up and even quicker to tear down, because to do either draws attention. But sport, like life, is almost always somewhere in the middle. Too bad, Armstrong’s story is not neat. They seldom are, those epics cluttered by flesh-and-blood. No matter how much we yearn them to be.

Metric, one of my favorite bands, has this lyric on their new album: “They were right when they said we should never meet our heroes.”  Perhaps it’s not so much that we shouldn’t meet them. Perhaps we need to be careful not to see them in absolutes.

cycling

Floyd Landis confession lets no one off the hook

The news that former Tour de France champion Floyd Landis has admitted using several performance-enhancing drugs in his cycling career, reported in The Wall Street Journal, is disappointing on several levels.

First, it invalidates one of the great performances in sports, Stage 17 of the 2006 Tour de France. Landis had lost his overall lead with a weak ride the day before, falling from first to 11th overall. He then stormed out to a solo breakaway that you never see from a contender in one of the great Tours. Riders who have fallen far back in the general classification may pull off a breakaway at times, but if someone of Landis’ caliber breaks free, the pack responds. The pack did indeed respond, but Landis was just that strong.

(Landis tells ESPN’s Bonnie Ford that the testosterone test that flagged him after that race is still inaccurate, but he admits he using human growth hormone.)

Second, it raises more doubt on cycling’s protracted clean-up efforts and, once again, on Lance Armstrong. Landis implicates much of American cycling’s pantheon — Armstrong, George Hincapie, Levi Leipheimer and David Zabriskie — though he concedes to Ford that he has no documentation.

Third, it makes us wonder if anti-doping efforts are helping at all. Any gloating from anti-doping activists — especially from Dick Pound, whose irresponsible comments about “violating virgins” in the early days of the Landis case showed a nasty tendency to talk first, gather facts later — would be misguided.

If there’s even a grain of truth in the e-mails Landis has sent to cycling and anti-doping authorities, then the tests are missing the mark. He tells Ford he is showing authorities how athletes are still cheating and beating the tests.

And yet, the test that flagged down Landis is still questionable. The site Trust But Verify meticulously cataloged problems with Landis’ case, and nothing Landis says here disputes any of that analysis. Arbitrator Chris Campbell ripped the French lab that handled the results in voting to dismiss Landis’ case, and the two arbitrators who overruled him conceded that mistakes had been made. Even if Landis were indeed using synthetic testosterone at that time, which he still denies, better handling of the case would’ve led to a much cleaner and quicker resolution.

Anti-doping science is difficult and ever-changing. Just ask Zach Lund, who missed the Torino Olympics over an anti-baldness drug that was later removed from the banned list. The tests are complicated, and athletes are finding ways to beat them.

And that’s why the anti-doping movement must always proceed out of humility rather than arrogance. Especially today.

Update: Christine Brennan sums up anti-doping challenges in reference to the case of Canadian doctor Anthony Galea, who paid house calls to Tiger Woods and Alex Rodriguez, with some telling quotes from someone who understands those challenges better than anyone — Gary Wadler.

olympic sports, track and field

LaShawn Merritt, male enhancement and unanswered questions

Startling news from track and field today: 2008 Olympic champion and 2009 world champion 400-meter runner LaShawn Merritt revealed that he has accepted a provisional suspension due to positive drug tests.

His championships aren’t at risk. In fact, none of his competitive results are at risk; the positives were recorded on out-of-competition tests since he last raced in September. The question is when he’ll be able to return to competition. If Merritt gets the standard two years, he’ll miss the 2011 World Championships.

But there are a few mitigating circumstances and oddities that need to be investigated.

The substance in question: a male enhancement product that he started using after last season. He didn’t realize it contained dehydroepiandrosterone (DHEA), a banned substance. Veteran Olympic sports reporter Philip Hersh (Tribune papers) says the product is ExtenZe, for which DHEA is prominently mentioned on the ingredients. (If you’re paranoid about what might happen if your Web browser’s cookies reveal you’ve browsed ExtenZe’s site, just take my word for it and don’t follow that link.)

USA Track and Field CEO Doug Logan, known to soccer fans as the first commissioner of Major League Soccer, released a blistering statement: “He has now put his entire career under a cloud and in the process made himself the object of jokes. In this day and age, a professional athlete should know better. Personally, I am disgusted by this entire episode.”

Merritt makes no effort to hide his embarrassment in his public statement.

As an athlete, and strong advocate of fair competition; I have worked
very hard to push myself to the outer limits of my physical abilities
without any performance enhancement drugs. I’ve always prided
myself on doing what’s right, and will continue to do so.

To know that I’ve tested positive as a result of product that I used for
personal reasons is extremely difficult to wrap my hands around.

But there’s something interesting in the press release issued by experienced athletes’ rights attorney Howard Jacobs. The tests were in October, December and January. Merritt wasn’t told of the tests, Jacobs’ release says, until March. He didn’t learn until “days ago” that the substance was DHEA.

A 5- or 6-month delay? That’s not supposed to happen. Check Article 7 of the World Anti-Doping Code (PDF).

Also a little odd, though it doesn’t mitigate the big ol’ “DHEA” on the ExtenZe ingredient list and on the Code’s 2010 prohibited list (PDF): You won’t find anything about that particular product by searching the GlobalDRO database site that is supposed to help athletes figure out if that bottle from the local vitamin store is on the up-and-up.

I’ve e-mailed the U.S. Anti-Doping Agency for comment and will pass on results.

Update: USADA confirms that Merritt had three urine samples with positive tests for “testosterone prohormones.” Merritt has accepted a provisional suspension, the investigation is ongoing, and the agency will comment again after that. No specific answer on the time gap between October and March. I’ve asked one follow-up: Have the B samples already been tested as well?